Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2012
06/28/2012US20120164159 Humanised Antibodies to Toll-Like Receptor 2 and Uses Thereof
06/28/2012US20120164158 Anti-ADDL Monoclonal Antibody and Use Thereof
06/28/2012US20120164155 Chimeric molecules
06/28/2012US20120164153 Monoclonal antibodies against glycoprotein of ebola sudan boniface virus
06/28/2012US20120164150 Monoclonal Antibodies Against Activated Protein C
06/28/2012US20120164149 Use of inhibitors of leukotriene b4 receptor blt2 for treating asthma
06/28/2012US20120164147 Mammalian genes; related reagents and methods
06/28/2012US20120164146 Isolated monophosphorylated peptide derived from human alpha-enolase useful for diagnosis and treatment of pancreatic adenocarcinoma, antibodies directed against the said monophosphorylated peptide, and uses thereof
06/28/2012US20120164145 H. pylori lipopolysaccharide outer core epitope
06/28/2012US20120164144 Novel anti-il13 antibodies and uses thereof
06/28/2012US20120164143 Human monoclonal antibodies against interleukin 8 (il-8)
06/28/2012US20120164138 Use of anti-cd1 antibodies for the modulation of immune responses
06/28/2012US20120164137 Anti-folate receptor alpha antibody glycoforms
06/28/2012US20120164135 Method for preparing comprehensive anti-surface antibody using microorganism immobilized as antigen with protein crosslinking and immobilization reagent
06/28/2012US20120164127 Mirac proteins
06/28/2012US20120164071 Compositions and Methods Comprising Phosphatidylethanolamine-Binding Peptide Derivatives
06/28/2012US20120164068 Immuno-conjugates and methods for producing them
06/28/2012CA2824279A1 Modified antibody with improved half-life
06/28/2012CA2824278A1 Modulating agonistic tnfr antibodies
06/28/2012CA2822684A1 Oprf/i agents and their use in hospitalized and other patients
06/28/2012CA2822515A1 Anti-il-18 antibodies and their uses
06/28/2012CA2820953A1 Anti-pcsk9 antibodies and methods of use
06/28/2012CA2820095A1 Isoform enriched antibody preparation and method for obtaining it
06/28/2012CA2819269A1 Anti-mesothelin antibodies and immunoconjugates
06/28/2012CA2819120A1 Stable immunogenic compositions of staphylococcus aureus antigens
06/28/2012CA2817519A1 Bin1 expression as a marker of skeletal muscle mass and neurological conditions
06/28/2012CA2817455A1 Detection of a polypeptide dimer by a bivalent binding agent
06/28/2012CA2817448A1 Binding agent
06/27/2012EP2468881A2 Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis
06/27/2012EP2468776A2 Anti-Robo4 antibodies and uses therefor
06/27/2012EP2468775A1 Anti-ICAM1 antibodies for inducing apoptosis
06/27/2012EP2468774A2 Antibody neutralizers of human granulocyte macrophage colony stimulating factor
06/27/2012EP2468773A2 Anti-GM-CSF Antibodies and uses therefor
06/27/2012EP2468772A2 Antibodies to EGFL7 and methods for their use
06/27/2012EP2468771A1 Pharmaceutical composition containing anti-hb-egf antibody as active ingredient
06/27/2012EP2468770A1 Humanized antibody against amyloid beta
06/27/2012EP2468769A1 Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
06/27/2012EP2468768A2 Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis
06/27/2012EP2468302A1 New indications for anti-IL-1beta therapy
06/27/2012EP2468301A1 New indications for anti-IL-1-beta therapy
06/27/2012EP2467499A1 Cstf2 for target genes of lung cancer therapy and diagnosis
06/27/2012EP2467492A2 Methods and compositions for the treatment of proliferative and pathogenic diseases
06/27/2012EP2467404A1 Anti p2x7 receptor antibodies and fragments thereof
06/27/2012EP2467403A2 Il1rap expression on acute and chronic myeloid leukemia cells
06/27/2012EP2467402A1 Anti-cmet antibody and its use for the detection and the diagnosis of cancer
06/27/2012EP2467401A2 Antibodies for the detection of integrin complexes in ffpe material
06/27/2012EP2467400A1 Variant immunoglobulins with improved manufacturability
06/27/2012EP2467393A1 New astrovirus species
06/27/2012EP2467169A1 In vivo screening assays
06/27/2012EP2467165A2 Targeted immunoconjugates
06/27/2012EP2467163A2 Mimotopes of hiv and uses thereof
06/27/2012EP2467156A1 Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agents
06/27/2012EP2174956B1 Compositions for anti-fibrinolitic treatment
06/27/2012EP2155788B1 Cross-species-specific bispecific binders
06/27/2012EP2086996B1 Marker specific for an oxidative degradation of tissues containing type iii collagen, means, methods and kits for the diagnosis, monitoring or prognosis of pathologies targeted by said marker
06/27/2012EP2068922B1 Anti-il-13r alpha 1 antibodies and their uses thereof
06/27/2012EP1976987B1 Cancer-associated Scratch variant
06/27/2012EP1960429B1 Immunoglobulins directed against nogo
06/27/2012EP1581171B1 Antibodies against gpr64 and uses thereof
06/27/2012EP1034277B1 Extracellular matrix-binding proteins from Staphylococcus aureus
06/27/2012CN102520174A Method related to detection of lung cancer by using lung cancer diagnostic reagent kit
06/27/2012CN102517381A Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
06/27/2012CN102517252A Biological materials and uses thereof
06/27/2012CN102516390A Preparation of multi-epitope TK-1 antibody, and application of multi-epitope TK-1 antibody in evaluating treatment effect on tumor patient
06/27/2012CN102516389A Method for extracting avian influenza egg yolk antibodies
06/27/2012CN102516388A Anthropogenic LMP1 (latent membrane protein1) extracellular regional antibody for nasopharyngeal carcinoma and application thereof
06/27/2012CN102516383A Novel mite allergen
06/27/2012CN102516372A A mutated immunoglobulin-binding protein
06/27/2012CN102516371A a mutated immunoglobulin-binding protein
06/27/2012CN102516370A Anti-HIV (human immunodeficiency virus) medicine target and use thereof in pharmacy
06/27/2012CN102516199A Compound and application thereof to sulfanilamide medicament detection
06/27/2012CN102516148A Half antigen and antigen of tenuazonic acid and preparation method and application thereof
06/27/2012CN102512675A Method for treating multiple sclerosis
06/27/2012CN102512670A Streptococcus pyogenes antigens
06/27/2012CN102512449A Method for removing viruses in preparation of antitoxin and antiserum
06/27/2012CN102071169B Hybridoma of DON (Deoxynivalenol) monoclonal antibody as well as preparation method and application thereof
06/27/2012CN102021146B West nile virus NS1 protein monoclonal antibody, identified B cell epitope thereof and application
06/27/2012CN101993855B Hybridoma cell line 1C11 and anti-aflatoxin general monoclonal antibody generated by same as well as applications thereof
06/27/2012CN101993492B ScFv antibody for resisting H5N1 type highly-pathogenic avian influenza and application thereof
06/27/2012CN101988050B H1N1 swine influenza virus-resistant hemagglutinin protein monoclonal antibody, hybridoma cell line and antigen-capture ELISA kit
06/27/2012CN101972479B Preparation process of intravenous injection human immunoglobulin
06/27/2012CN101863976B Preparation method of EV71 virus antibody
06/27/2012CN101838650B Development and applications of new human gene FAMLF in human gene recombination, malignant tumor gene detection and specific monoclonal antibody
06/27/2012CN101830980B Chlorothalonil antigen, antibody preparation method and residual chlorothalonil ELISA (Enzyme-Linked Lmmuno Sorbent Assay) detection method
06/27/2012CN101808668B Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition
06/27/2012CN101724074B Humanized chimeric antibody of angiostatin receptor beta subunit, preparation thereof and application thereof
06/27/2012CN101717447B Method for preparing antihuman recombinant tissue factor monoclonal antibody
06/27/2012CN101717445B Preparing method of egg yolk antibody
06/27/2012CN101591393B Hydrophobia-tetanus double titer human immunoglobulin, method for preparing same and application thereof in pharmacy
06/27/2012CN101553568B Neukinase, a downstream protein of neuregulin
06/27/2012CN101463344B Antihuman Her2 monoclonal antibody hybridoma cell lines, monoclonal antibody, reagent kit and uses thereof
06/27/2012CN101463086B Diethoxy thiophosphate organophosphorus pesticide antibody, and preparation and use thereof
06/27/2012CN101460623B Novel anti-CD98 antibody
06/27/2012CN101343320B Anti-vibrio parahaemolyticus chicken yolk antibody, preparation method and application thereof
06/27/2012CN101233156B Cd19 antibodies and their uses
06/27/2012CN101133085B Assay method for human orotate phosphoribosyltransferase protein
06/27/2012CN101107268B Specific binding members for NGF
06/27/2012CN101043947B Method of antibody purification
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8207315 Expression vector comprising nucleotide sequence coding angiogenic factor (VG5Q protein) for use in identifying modulators which reduce tumor necrosis factor-like weak inducer of apoptosis (TWEAK) activity and treat or prevent cell proliferative disorders
1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 1494